老年重症肢体缺血不同治疗策略的预期寿命与结局
该研究纳入2006至2013年≥70岁慢性重症肢体缺血患者651例(686条患肢),比较保守、腔内、外科或一期大截肢治疗的生存差异,并按年龄和性别与荷兰总人群比较死亡率和预期寿命;总体1年死亡率为29%,保守治疗相对非保守治疗的死亡风险比为0.84(95%CI 0.65-1.09;P=0.19)。
要点
- 老年重症肢体缺血患者总体1年死亡率为29%。
- 保守治疗相对非保守治疗的死亡风险比为0.84(95%CI 0.65-1.09;P=0.19)。
- 80岁及以上患者腔内和外科术后死亡风险比高于70-79岁患者(均P<0.001)。
核心结论
- 老年重症肢体缺血患者死亡率高且预期寿命缩短,与干预类型无关。
- 血运重建围手术期死亡率高,尤其80岁及以上患者。
- 保守治疗在死亡率方面不劣于非保守治疗,合并症多的80岁及以上患者应考虑保守治疗。
研究设计与样本
- 回顾性纳入2006至2013年≥70岁慢性重症肢体缺血患者651例(686条患肢)。
- 初始治疗分为保守(n=181)、腔内(n=259)、外科(n=169)或截肢(n=42)。
- 按年龄分层为70-79岁(n=350)和≥80岁(n=301),并与荷兰总人群按年龄和性别比较死亡率和预期寿命。
主要发现
- 总体1年死亡率为29%。
- 80岁及以上患者腔内和外科术后死亡风险比高于70-79岁患者(均P<0.001)。
- 保守治疗相对非保守治疗的死亡风险比为0.84(95%CI 0.65-1.09;P=0.19),两年龄组间无显著差异(P=0.74)。
- 研究人群相对荷兰总人群的死亡风险比为3.72,超额死亡率为272%。
- 70岁时男性和女性预期寿命分别缩短9年和8年。
临床怎么用
- 对老年重症肢体缺血患者应评估合并症和衰弱程度,权衡血运重建围手术期风险。
- 80岁及以上合并症多的患者可考虑保守治疗,其死亡率不劣于非保守治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The treatment of critical limb ischemia (CLI) in the elderly patients is challenging because of the comorbidity and fragility of these patients. We analyzed survival in relation to different treatment options and estimated life expectancy of our study group by age and gender. METHODS: All patients aged ≥70 years, presenting with chronic CLI, between 2006 and 2013 were included. The treatment was conservative, endovascular, surgical, or by primary major amputation. The interest was in the effect of conservative versus nonconservative treatment on survival. Furthermore, we compared mortality and life expectancy between the study population to the overall Dutch population by age and gender. RESULTS: In total, 686 legs in 651 patients were treated. Initial treatment of patients was conservative (n = 181), endovascular (n = 259), surgical (n = 169), or amputation (n = 42). The overall 1-year mortality was 29%. Patients were stratified by age: 70-79 (n = 350) years and ≥80 (n = 301) years. Higher mortality rate ratios (RR) were found in octogenarians compared with patients aged 70-79 years, in the endovascular (P < 0.001) and surgical (P < 0.001) group. The mortality RRs of conservative relatively to nonconservative treatment was 0.84 (95% confidence interval: 0.65-1.09; P = 0.19), not significantly differing between both age groups (P = 0.74). The mortality RR of 3.72 of our study population to the Dutch general population was high, with an excess mortality of 272%. Life expectancy at the age of 70 years was substantially decreased by 9 and 8 years for, respectively, the male and female population. CONCLUSIONS: Mortality rates in elderly patients with CLI are high, corresponding with a decreased life expectancy, regardless of the type of intervention. Revascularization is associated with high periprocedural mortality, especially in octogenarians. Conservative treatment is noninferior to nonconservative treatment in terms of mortality and should be considered as the treatment in octogenarians with substantial comorbidity.
引用
- Klaphake S, de Leur K, Mulder PGH, et al. Life Expectancy and Outcome of Different Treatment Strategies for Critical Limb Ischemia in the Elderly Patients. Ann Vasc Surg. 2017. PMID: 28689942. doi:10.1016/j.avsg.2017.06.141
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。